AFM
BSTG

Anson Funds Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Anson Funds Management’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-649,147
Closed -$740K – 72
2016
Q2 		$740K Buy
+649,147
New +$1.05M 0.14% 48

Other funds holding BSTG

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Anson Funds Management's BSTG Position: Q3 2016 in Review

Anson Funds Management sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2016, closing a stake of 649,147 shares — an estimated $740K sold.

Anson Funds Management first reported a position in BSTG in Q2 2016 and held it in 1 quarter. The position peaked at $740K in Q2 2016. 26 funds tracked by Wall St. Rank hold BSTG as of Q3 2016.

  • Anson Funds Management reported no remaining Biostage, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Anson Funds Management sold 649,147 Biostage, Inc. Common Stock shares in Q3 2016, an estimated $740K.
  • Anson Funds Management first reported a position in Biostage, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
  • Anson Funds Management's Biostage, Inc. Common Stock position peaked at $740K in Q2 2016.
  • 26 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2016.

Based on Anson Funds Management's 13F filing for Q3 2016, filed 14 Nov 2016.